Montes Claros recorded its first confirmed case of mpox in 2026 this week, when a laboratory result came back positive for a 41-year-old man, the municipal health department and the G1 news service reported.
The case is encouraging rather than alarming: no severe cases or hospitalizations have been registered anywhere in Minas Gerais this year, according to the state health ministry.
The confirmation matters because it shows the surveillance system working as designed, not failing. The state has counted 41 confirmed mpox cases from January through November 2026 — down from 136 notifications in 2025 and 68 in 2024, according to data compiled by Estado de Minas from the State Health Secretariat (SES-MG). The decline is running against the arrival of the virus in a city that had not yet reported a confirmed case.
A case that took twelve days to confirm
On November 9, he sought medical care with fever, chills, headache, abdominal pain, diarrhea, sore throat, a urinary infection, and skin marks and eruptions. The case was formally notified as suspected on November 11, and the laboratory confirmed the diagnosis on Monday, November 16.
According to the epidemiological investigation, the man told health officials he had recently traveled to Belo Horizonte — where he also maintains a residence — and to Janaúba, in northern Minas. He denied contact with anyone showing similar symptoms. That gap matters: without an identified source, contact tracing carries more of the containment burden.

Once the lab result arrived, the municipal network identified everyone who had contact with the patient. Preventive follow-up is being handled by the Family Health Strategy teams — the local primary-care units responsible for that coverage area, the prefecture said.
Montes Claros case sits among higher counts
Estado de Minas reports that Juiz de Fora is the city with the second-most confirmed cases in Minas in 2026, and Divinópolis has confirmed two cases this year while investigating two more suspected ones, according to Globo. The state label lists Montes Claros’s single case against those higher counts — a modest number, but a new territory for the virus this year.
- The first symptoms appeared on November 4, while the patient was still in Montes Claros (RCWTV).
- The case was notified as suspected on November 11, and the laboratory confirmed it on November 16 (RCWTV).
- On November 19, the prefecture announced the confirmation — the city’s first of 2026 (G1).
Statewide, testing runs through the Central Public Health Laboratory (Lacen-MG/Funed) and decentralized units in Juiz de Fora and Diamantina. Diagnosis analyzes secretions or crusts from the lesions. There is no specific treatment; care focuses on relieving symptoms and preventing complications, according to SES-MG.
Mpox spreads through contact and lesions
- Mpox spreads through direct contact with skin lesions, sexual contact, respiratory secretions, or shared contaminated objects. A single confirmed case with contact tracing underway is not an outbreak.
- The telltale sign is sores or blisters on the skin, often with fever. If you notice these, go to a basic health unit for testing — the state’s subsecretary of health surveillance says exactly that.
- Most people have a mild-to-moderate illness. Minas has recorded no severe cases or hospitalizations from mpox this year.
Symptoms, spread, and who gets vaccinated
Mpox is caused by the mpox virus (MPXV). Infection runs a mild-to-moderate course in most people, per the state secretariat’s summary. The confirmed Minas cases this year are concentrated among men aged 15 to 34.
“It is important that people pay attention to symptoms, especially the sores, which are the most characteristic, and seek a Basic Health Unit for testing,” said Eduardo Prosdocimi, Subsecretary of Health Surveillance at SES-MG, in remarks translated from Portuguese.
“We have no severe cases or hospitalizations in the state, but preventive measures are necessary,” Prosdocimi said.
Vaccination in Minas follows a strict priority list. It covers people living with HIV/AIDS with immunosuppression and a CD4 T-lymphocyte count below 200 cells in the last six months; laboratory professionals working at biosafety level 2; and people exposed to fluids or secretions from suspected cases. After a known exposure, the dose should be given preferably within four days, extendable to 14 days if no symptoms appear.
Three years of mpox in Minas, by the numbers
| Year | Cases reported in Minas Gerais | Severe cases/hospitalizations |
|---|---|---|
| 2024 | 68 notifications | Not reported by SES-MG |
| 2025 | 136 notifications | Not reported by SES-MG |
| 2026 (Jan–Nov) | 41 confirmed | None, per SES-MG |
The state’s coordination team for sexually transmitted infections, AIDS, and viral hepatitis reviews the data daily and updates the epidemiological panel weekly. Prosdocimi told Estado de Minas the state’s teams are in constant contact with municipal professionals on diagnosis and case management: “Therefore, we are controlling the cases that are emerging.”
Seek care for lesions and fever
Mpox has no specific antiviral treatment in routine use in Brazil’s public network, so the clinical triage question is not drug choice but severity and exposure. Seek care at a basic health unit if you develop characteristic skin lesions, especially alongside fever, swollen lymph nodes, or known contact with a confirmed or suspected case.
The vaccine priority criteria are narrow: immunosuppressed people living with HIV/AIDS with a CD4 count below 200 cells, certain laboratory workers, and recent exposed contacts. Outside those groups, prevention rests on avoiding direct contact with lesions and not sharing contaminated objects. People with extensive lesions, difficulty swallowing, breathing difficulty, or signs of secondary infection need prompt professional evaluation rather than home care.
What remains open
Two questions stay unanswered in this case. Health officials have not established where the man contracted the virus, since he reported no contact with symptomatic people despite travel to Belo Horizonte and Janaúba. And the follow-up of his close contacts by the Family Health Strategy teams is still underway, so whether transmission has extended beyond this single patient is not yet known.
Montes Claros, where the man first showed symptoms on November 4, sits in northern Minas Gerais, about 422 km from Belo Horizonte, and counted 414,240 residents in the 2022 census — the fifth most populous municipality in the state. Its origins trace to the Montes Claros Farm, granted to the bandeirante Antônio Gonçalves Figueira by royal charter on April 12, 1707, at the headwaters of the Verde Grande River.
A settlement grew around a chapel built by a descendant of the farm’s later owners, and the village was elevated to city status under the law of July 3, 1857 — the date the city still celebrates as its anniversary.
The weekly state epidemiological panel, updated by the SES-MG coordination, is where the next confirmed count for Montes Claros — or a second case — will first appear.
References
- RÁDIO Globo/G1 Minas — report on the confirmation of Montes Claros’s first 2026 mpox case: G1.
- Estado de Minas — Minas strengthens mpox surveillance and registers declining cases: Estado de Minas.
- Minas Gerais State Health Secretariat (SES-MG) — epidemiological data and vaccination criteria as cited by the outlets above
- Divinópolis and Juiz de Fora municipal case reports as cited by Portal UAI and Acessa.com.